首页期刊介绍编委会投稿指南期刊订阅广告合作留言板联系我们English
龚姗,李弘,刘叶倩,陈春茗,马丹凤,刘林,任卫琼.复方七芍降压片对 TNF-α 诱导的与平滑肌细胞共培养的血管内皮细胞中炎症因子与 AP-1、MCP-1 蛋白表达的影响[J].中国实验动物学报,2020,28(6):733~741.
复方七芍降压片对 TNF-α 诱导的与平滑肌细胞共培养的血管内皮细胞中炎症因子与 AP-1、MCP-1 蛋白表达的影响
Effects of compound Qishao Jiangya tablet on inflammatory factors, AP-1 and MCP-1 in vascular endothelial cells stimulated with TNF-α and co-cultured with smooth muscle cells
投稿时间:2020-06-01  
DOI:10. 3969 / j.issn.1005-4847. 2020. 06. 001
中文关键词:  炎症  AP-1  MCP-1  内皮细胞  平滑肌细胞  复方七芍降压片
英文关键词:inflammation  AP-1  MCP-1  endothelial cell  smooth muscle cell  compound Qishao Jiangya tablet Conflicts of Interest: The authors declare no conflict of interest.
基金项目:
作者单位E-mail
龚姗 湖南中医药大学第一附属医院,长沙 410007 564291733@ qq.com 
李弘 湖南中医药大学第一附属医院,长沙 410007  
刘叶倩 湖南中医药大学第一附属医院,长沙 410007  
陈春茗 湖南中医药大学第一附属医院,长沙 410007  
马丹凤 湖南省儿童医院,长沙 410006  
刘林 湖南中医药大学第一附属医院,长沙 410007  
任卫琼 湖南中医药大学第一附属医院,长沙 410007 renweiqiong1@ 126.com 
摘要点击次数: 249
全文下载次数: 103
中文摘要:
       目的 观察复方七芍降压片对 TNF-α 诱导的与平滑肌细胞共培养的血管内皮细胞中炎症因子与 AP-1、MCP-1 蛋白表达情况,探讨复方七芍降压片抑制血管重塑的作用机制。 方法 利用炎症因子 TNF-α 联合血管内皮细胞和血管平滑肌细胞共培养体系构建高血压炎症环境。将共培养好的细胞随机分为 7 组,即正常对照组 (A)、模型组(B)、空白血清对照组(C)、MRS2578 组(D)、厄贝沙坦片含药血清组(E)、复方七芍降压片含药血清组 (F)、MRS2578 + 复方七芍降压片含药血清组(G)。除正常对照组外,其余各组加入炎症因子 TNF-α,浓度 10 ng / mL;厄贝沙坦片含药血清组、复方七芍降压片含药血清组和 MRS2578 + 复方七芍降压片含药血清组加入 10%的含药血清;MRS2578 组与 MRS2578 + 复方七芍降压片含药血清组加入 10 μm 的 P2Y6 受体阻断剂 MRS2578;造模与 给药干预 24 h 后,采用 CCK8 法检测内皮细胞及平滑肌细胞的存活率;采用 ELISA 法检测培养基上清液中炎症因子 IL-8 的水平;采用免疫荧光、Western Blot、实时荧光定量法( qPCR)技术检测内皮细胞中 AP-1、MCP-1 的表达。 结果 与正常对照组比较,模型组和空白血清对照组内皮细胞及平滑肌细胞存活率明显降低(P< 0. 01),IL-8 水平明显升高(P< 0. 01),内皮细胞中 AP-1、MCP-1 的荧光强度值、灰度值比值、mRNA 水平均明显升高(P < 0. 01);与 模型组比较,复方七芍降压片含药血清组内皮细胞及平滑肌细胞存活率明显升高(P < 0. 01),IL-8 水平明显降低 (P < 0. 05),内皮细胞中 AP-1、MCP-1 荧光强度值、灰度值比值、mRNA 水平均明显降低(P < 0. 01)。 结论 复方七芍降压片能够改善因炎症因子 TNF-α 诱导的内皮细胞及平滑肌细胞的存活率,降低 AP-1 和 MCP-1 的活性,抑制内皮细胞炎症反应,改善内皮损伤,保护平滑肌细胞正常功能。
英文摘要:
       Objective To observe the expression levels of inflammatory factors, AP-1, and MCP-1 in TNF-α- stimulated vascular endothelial cells and co-cultured with smooth muscle cells following treatment with the compound Qishao Jiangya tablet, and explore the mechanism by which the compound Qishao Jiangya tablet inhibits vascular remodeling. Methods A co-culture system was established using vascular endothelial cells and smooth muscle cells. Stimulation with TNF-α was used to mimic the hypertensive inflammatory environment. The cultured cells were randomly divided into seven groups: normal control, model, blank serum control, MRS2578, irbesartan tablet drug-containing serum, compound Qishao Jiangya tablet-containing serum, and MRS2578 + compound Qishao Jiangya tablet-containing serum. Except the normal control group, all groups were stimulated with 10 ng / mL TNF-α; the irbesartan tablet drug-containing serum, compound Qishao Jiangya tablet-containing serum, and MRS2578+compound Qishao Jiangya tablet-containing serum were treated with 10% drug-containing serum; the MRS2578 and MRS2578+compound Qishao Jiangya tablet drug-containing serum groups were treated with 10 μm P2Y6 receptor blocker MRS2578. After 24 hours of modeling and drug intervention, CCK8 assays were used to detect the survival rates of endothelial cells and smooth muscle cells. ELISA was used to detect the level of IL-8 in the culture supernatant. Immunofluorescence, Western Blot, and quantitative PCR were used to detect endothelial expression levels of AP-1 and MCP-1. Results Compared with the normal control group, the survival rates of smooth muscle and endothelial cells decreased significantly in the model and blank serum control groups, while the levels of IL-8 were significantly higher (P < 0. 01). Compared with the normal control group,AP-1 and MCP-1 in endothelial cells in the model and blank serum control groups were detected by fluorescence intensity value of immunofluorescence, gray value ratio by Western Blot, and mRNA levels by quantitative PCR were significantly increased (P< 0. 01). Compared with the model group, the survival rates of smooth muscle and endothelial cells were significantly increased in the compound Qishao Jiangya tablet-containing serum groups, while the levels of IL-8 were significantly lower (P < 0. 05). AP-1 and MCP-1 in endothelial cells were detected by fluorescence intensity value of immunofluorescence, gray value ratio by Western blotting, and mRNA levels by quantitative PCR in the compound Qishao Jiangya tablet-containing serum groups were significantly reduced compared with the model group(P < 0. 01). Conclusions Following stimulation with TNF-α, the compound Qishao Jiangya tablet can improve the survival rates of endothelial cells and smooth muscle cells, reduce the levels of AP-1 and MCP-1, prevent endothelial cell inflammation, improve endothelial damage, and protect normal function of smooth muscle cells.
查看全文  查看/发表评论  下载PDF阅读器
关闭
您是第 1937556 位访问者
版权所有:中国实验动物学会 主管单位:中国科学技术协会 主办单位:中国实验动物学会    中国医学科学院医学实验动物研究所
地  址: 北京市朝阳区潘家园南里5号 邮编:100021 电话:010-67779337 E-mail:bjb2@cnilas.org
本系统由北京勤云科技发展有限公司设计
微信关注二维码